recombinant human collagen (JHM Group)

Recombinant human collagen (JHM Group) is a bioengineered protein material comprising Recombinant Type I and Type III human collagen, designed to be structurally identical to native human collagen with a full-length triple-helical structure. Developed by JHM Biopharmaceutical (Hangzhou) Co., Ltd. (JHM Group) using synthetic biology and large-scale 20-ton fermentation and purification processes, this raw material serves as a bioactive scaffold for medical devices in regenerative medicine, tissue engineering, and medical aesthetics. It is utilized as the active ingredient in various formulated products, such as wound dressings, repair solutions, and dermal fillers, to promote tissue repair, wound healing, and anti-aging effects. While the raw material itself is regulated as a medical device component rather than a standalone pharmaceutical drug, it is applied or injected to facilitate healing and tissue augmentation in clinical and aesthetic settings.

Other names

重组人胶原蛋白原料Recombinant Human Collagen Raw MaterialJHM recombinant human collagen